vs
Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
INSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($159.9M vs $151.7M, roughly 1.1× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 4.7%, a 3.1% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-2.2M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 12.0%).
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
IIIN vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $159.9M | $151.7M |
| Net Profit | $7.6M | $11.8M |
| Gross Margin | 11.3% | 30.4% |
| Operating Margin | 6.0% | 20.4% |
| Net Margin | 4.7% | 7.8% |
| Revenue YoY | 23.3% | -41.1% |
| Net Profit YoY | 602.4% | -80.8% |
| EPS (diluted) | $0.39 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $159.9M | $151.7M | ||
| Q3 25 | $177.4M | $267.8M | ||
| Q2 25 | $179.9M | $244.0M | ||
| Q1 25 | $160.7M | $211.8M | ||
| Q4 24 | $129.7M | $257.6M | ||
| Q3 24 | $134.3M | $78.8M | ||
| Q2 24 | $145.8M | $76.1M | ||
| Q1 24 | $127.4M | $67.5M |
| Q4 25 | $7.6M | $11.8M | ||
| Q3 25 | $14.6M | $55.4M | ||
| Q2 25 | $15.2M | $-17.7M | ||
| Q1 25 | $10.2M | $21.2M | ||
| Q4 24 | $1.1M | $61.6M | ||
| Q3 24 | $4.7M | $-8.8M | ||
| Q2 24 | $6.6M | $-364.0K | ||
| Q1 24 | $6.9M | $-364.0K |
| Q4 25 | 11.3% | 30.4% | ||
| Q3 25 | 16.1% | 57.8% | ||
| Q2 25 | 17.1% | 51.2% | ||
| Q1 25 | 15.3% | 55.9% | ||
| Q4 24 | 7.3% | 55.0% | ||
| Q3 24 | 9.1% | 27.8% | ||
| Q2 24 | 10.6% | 29.7% | ||
| Q1 24 | 12.3% | 15.1% |
| Q4 25 | 6.0% | 20.4% | ||
| Q3 25 | 10.8% | 48.7% | ||
| Q2 25 | 11.0% | 13.8% | ||
| Q1 25 | 8.3% | 38.1% | ||
| Q4 24 | 1.1% | 44.4% | ||
| Q3 24 | 4.5% | 12.3% | ||
| Q2 24 | 6.0% | 7.0% | ||
| Q1 24 | 7.0% | 2.1% |
| Q4 25 | 4.7% | 7.8% | ||
| Q3 25 | 8.2% | 20.7% | ||
| Q2 25 | 8.4% | -7.3% | ||
| Q1 25 | 6.4% | 10.0% | ||
| Q4 24 | 0.8% | 23.9% | ||
| Q3 24 | 3.5% | -11.2% | ||
| Q2 24 | 4.5% | -0.5% | ||
| Q1 24 | 5.4% | -0.5% |
| Q4 25 | $0.39 | $2.34 | ||
| Q3 25 | $0.74 | $7.76 | ||
| Q2 25 | $0.78 | $-2.95 | ||
| Q1 25 | $0.52 | $3.33 | ||
| Q4 24 | $0.06 | $11.56 | ||
| Q3 24 | $0.24 | $-1.72 | ||
| Q2 24 | $0.34 | $-0.07 | ||
| Q1 24 | $0.35 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.6M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $358.8M | $329.4M |
| Total Assets | $456.1M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | $185.6M | ||
| Q3 25 | $38.6M | $166.0M | ||
| Q2 25 | $53.7M | $96.7M | ||
| Q1 25 | $28.4M | $84.7M | ||
| Q4 24 | $36.0M | $40.6M | ||
| Q3 24 | $111.5M | $46.9M | ||
| Q2 24 | $97.7M | $40.8M | ||
| Q1 24 | $83.9M | $30.0M |
| Q4 25 | $358.8M | $329.4M | ||
| Q3 25 | $371.5M | $317.2M | ||
| Q2 25 | $356.2M | $235.3M | ||
| Q1 25 | $341.4M | $176.9M | ||
| Q4 24 | $331.6M | $132.4M | ||
| Q3 24 | $350.9M | $60.4M | ||
| Q2 24 | $346.0M | $62.7M | ||
| Q1 24 | $340.6M | $63.0M |
| Q4 25 | $456.1M | $918.5M | ||
| Q3 25 | $462.6M | $964.5M | ||
| Q2 25 | $471.9M | $841.0M | ||
| Q1 25 | $421.9M | $761.9M | ||
| Q4 24 | $404.7M | $655.3M | ||
| Q3 24 | $422.6M | $438.5M | ||
| Q2 24 | $414.6M | $422.4M | ||
| Q1 24 | $397.2M | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-701.0K | $70.4M |
| Free Cash FlowOCF − Capex | $-2.2M | $69.0M |
| FCF MarginFCF / Revenue | -1.4% | 45.5% |
| Capex IntensityCapex / Revenue | 0.9% | 0.9% |
| Cash ConversionOCF / Net Profit | -0.09× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $439.0K | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-701.0K | $70.4M | ||
| Q3 25 | $-17.0M | $99.5M | ||
| Q2 25 | $28.5M | $27.3M | ||
| Q1 25 | $-3.3M | $51.0M | ||
| Q4 24 | $19.0M | $54.0K | ||
| Q3 24 | $16.2M | $6.8M | ||
| Q2 24 | $18.8M | $13.3M | ||
| Q1 24 | $1.4M | $3.1M |
| Q4 25 | $-2.2M | $69.0M | ||
| Q3 25 | $-18.7M | $99.2M | ||
| Q2 25 | $26.9M | $26.5M | ||
| Q1 25 | $-5.5M | $50.9M | ||
| Q4 24 | $16.3M | $-341.0K | ||
| Q3 24 | $14.5M | $6.2M | ||
| Q2 24 | $15.5M | $12.7M | ||
| Q1 24 | $-580.0K | $2.3M |
| Q4 25 | -1.4% | 45.5% | ||
| Q3 25 | -10.6% | 37.0% | ||
| Q2 25 | 15.0% | 10.9% | ||
| Q1 25 | -3.5% | 24.0% | ||
| Q4 24 | 12.6% | -0.1% | ||
| Q3 24 | 10.8% | 7.8% | ||
| Q2 24 | 10.7% | 16.7% | ||
| Q1 24 | -0.5% | 3.4% |
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 1.0% | 0.1% | ||
| Q2 25 | 0.9% | 0.3% | ||
| Q1 25 | 1.4% | 0.0% | ||
| Q4 24 | 2.1% | 0.2% | ||
| Q3 24 | 1.3% | 0.8% | ||
| Q2 24 | 2.2% | 0.7% | ||
| Q1 24 | 1.5% | 1.1% |
| Q4 25 | -0.09× | 5.95× | ||
| Q3 25 | -1.17× | 1.80× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | -0.32× | 2.40× | ||
| Q4 24 | 17.56× | 0.00× | ||
| Q3 24 | 3.48× | — | ||
| Q2 24 | 2.86× | — | ||
| Q1 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
